In the media 3 Apr 2024 Comme la Guinée avec la maladie du sommeil, 44 pays ont réussi à éradiquer des pathologies depuis cinq ans Le Monde
Viewpoints 3 Apr 2025 Africa’s greatest health challenges won’t be solved without female scientists TRT Afrika
Scientific articles 31 Mar 2025 Discovery and early optimization of 1H-indole-2-carboxamides with anti-Trypanosoma cruzi activity Journal of Medicinal Chemistry
Press releases 18 Mar 2025 DNDi welcomes GHIT support for new collaboration with Shionogi to identify novel drug candidates for neglected Chagas disease
Scientific articles 11 Mar 2025 Unsupervised machine learning identifies biomarkers of disease progression in post-kala-azar dermal leishmaniasis in Sudan PLOS Neglected Tropical Diseases
Scientific articles 27 Sep 2022 Paromomycin and miltefosine combination as an alternative to treat patients with visceral leishmaniasis in Eastern Africa: A randomized, controlled, multicountry trial Clinical Infectious Diseases
Scientific articles 27 Sep 2022 Safety and efficacy of oral fexinidazole in children with gambiense human African trypanosomiasis: a multicentre, single-arm, open-label, phase 2/3 trial The Lancet Global Health
Scientific articles 26 Sep 2022 Communities’ perception, knowledge, and practices related to human African trypanosomiasis in the Democratic Republic of Congo Diseases
Scientific articles 20 Sep 2022 Our current understanding of Chagas disease and Trypanosoma cruzi infection in the State of Florida – an update on research in this region of the USA Current Tropical Medicine Reports
Scientific articles 4 Sep 2022 A pharmacometric approach to evaluate drugs for potential repurposing as COVID-19 therapeutics Expert Review of Clinical Pharmacology
Scientific articles 18 Aug 2022 The increasing incidence of visceral leishmaniasis relapse in South Sudan: A retrospective analysis of field patient data from 2001–2018 PLOS Neglected Tropical Diseases
Scientific articles 16 Aug 2022 Discovery of substituted di(pyridin-2-yl)-1,2,4-thiadiazol-5-amines as novel macrofilaricidal compounds for the treatment of human filarial infections Journal of Medicinal Chemistry
Scientific articles 12 Aug 2022 Need for a standardized translational drug development platform: Lessons learned from the repurposing of drugs for COVID-19 Microorganisms
Scientific articles 4 Aug 2022 A phase-2, randomized, multicenter, placebo-controlled, proof-of-concept trial of oral fexinidazole in adults with chronic indeterminate Chagas disease Clinical Infectious Diseases
Scientific articles 1 Aug 2022 Nuevos enfoques terapéuticos de la infección por T. cruzi/ Enfermedad de Chagas Ciencia e Investigación
Scientific articles 30 Jul 2022 Epidemiological cut-off values for itraconazole and ravuconazole for Madurella mycetomatis, the most common causative agent of mycetoma Mycoses
Scientific articles 19 Jul 2022 Definitions matter: Heterogeneity of COVID-19 disease severity criteria and incomplete reporting compromise meta-analysis PLOS Global Public Health
Scientific articles 10 Jul 2022 Pre-clinical evaluation of antiviral activity of nitazoxanide against SARS-CoV-2 eBioMedicine
Scientific articles 6 Jul 2022 Chagas disease control-surveillance in the Americas: The multinational initiatives and the practical impossibility of interrupting vector-borne Trypanosoma cruzi transmission Memórias do Instituto Oswaldo Cruz
Scientific articles 4 Jul 2022 Development and validation of a high-performance liquid chromatography tandem mass spectrometry method for the quantification of the antiparasitic and antifungal drug amphotericin B in human skin tissue Journal of Chromatography B
